思微合成生技股份有限公司
Update:2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
1. Biomedical Drug Synthesis
2. Semiconductor Material Synthesis
3. Contract Research and Development (FTE)
4. Customized Services (Including CRO and CMO Services)
5. Antibody-Drug Conjugates (ADC)
2. Semiconductor Material Synthesis
3. Contract Research and Development (FTE)
4. Customized Services (Including CRO and CMO Services)
5. Antibody-Drug Conjugates (ADC)
The content above was translated by Ai
Founded Year
2023
Unified Business No.
93539342
Status
Active
Number of Employees
0
Total Paid-in
Capital
35,150,000 (NT$)
Location of Company
Taiwan
, New Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
思微合成生技 possesses professional organic synthesis technology, has completed a series of important projects in the industry, and has a wide scope of services. Our clients include important institutions such as Formosa Laboratories, Handa Biotech, SyneuRx, Panlabs, Foresee Pharmaceuticals, Academia Sinica, the National Chung-Shan Institute of Science and Technology, MacKay Memorial Hospital Laboratory, Chang Gung University, National Taiwan University, National Chiao Tung University Organic Laboratory, and New Applied Materials.
Our R&D team possesses over 10 to 20 years of pharmaceutical GMP experience. In addition to specializing in small-scale (mg) synthesis, we also provide clients with large-scale (kg) process development. We are able to provide professional process optimization services for our clients and assist in introducing products into GMP facilities for GMP-grade scale-up processes. Relying on our unique organic synthesis R&D technology, we are committed to providing our clients with the highest quality services.
Our R&D team possesses over 10 to 20 years of pharmaceutical GMP experience. In addition to specializing in small-scale (mg) synthesis, we also provide clients with large-scale (kg) process development. We are able to provide professional process optimization services for our clients and assist in introducing products into GMP facilities for GMP-grade scale-up processes. Relying on our unique organic synthesis R&D technology, we are committed to providing our clients with the highest quality services.
The content above was translated by Ai